In LAM patient-derived lung cells, AML kidney-derived LAM cell lines and mouse Tsc2-null TTJ cells, we showed that rapamycin was an effective inhibitor of pS6 (Ser235/236) but a poor inhibitor of p4E-BP1 (Thr37/46). This evidence concerns the gene EIF4EBP1 and lymphangioleiomyomatosis.